Home » Topics » BioWorld Science

BioWorld Science
RSS

Biomira and Intracel negotiate acquisition of certain Biomira assets

Nov. 17, 1997

Amylin Pharmaceuticals: Q3 1997 highlights

Nov. 17, 1997

Celecoxib: safety and efficacy data presented at rheumatology meeting

Nov. 17, 1997

Novartis submits BLA for Simulect in U.S.

Nov. 17, 1997

Cardioprotective activity of monoHER demonstrated in preclinical models

Nov. 17, 1997

Results reported for Myriad's CardiaRisk

Nov. 17, 1997

S-Nitrosocaptopril exerts both acute and chronic hypotensive effects in rats

Nov. 17, 1997

Roche resubmits NDA for Xenical

Nov. 17, 1997

P&G kicks off U.S. arm of ALIVE trial

Nov. 17, 1997

Roche launches Fortovase in U.S.

Nov. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...